Melatonin for Treatment of Delirium in Critically Ill Adult Patients
Status:
Not yet recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the feasibility of conducting a randomized
controlled trial (RCT) with melatonin for treatment of delirium in critically ill adult
patients. From a feasibility perspective, we believe that the proposed design will achieve
the minimum enrollment rate necessary to conduct a future RCT on a larger scale.